Extensive testing may be unnecessary for early esophageal cancer patients

A new study suggests that multiple staging scans don't alter treatment decisions for patients with early-stage esophageal adenocarcinoma or precancerous lesions. The finding could reduce healthcare costs and patient burden by streamlining diagnostic protocols in a condition affecting thousands annually.

Originaltitel: Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma